Alvarez, Edgardo A.

HRN: 26-62-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2025
CEFUROXIME 750MG (VIAL)
10/03/2025
10/10/2025
IVT
260mg
Q8
AGE With Moderate Dehydration; URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTIIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: